Have a symptom?
See what questions
a doctor would ask.
Diseases » Acidemia, methylmalonic » Prevalence

Prevalence and Incidence of Acidemia, methylmalonic

Prevalance of Acidemia, methylmalonic:

estimated 1 per 50,000 - 100,000 suffer from Methylmalonic acidemia, Genetics Home Reference website ... see also overview of Acidemia, methylmalonic.

Prevalance Rate:

approx 1 in 50,000 or 0.00% or 5,440 people in USA [Source statistic for calcuation: "estimated 1 per 50,000 - 100,000 suffer from Methylmalonic acidemia, Genetics Home Reference website" -- see also general information about data sources]

Acidemia, methylmalonic: Rare Disease

Acidemia, methylmalonic is listed as a "rare disease" by the Office of Rare Diseases (ORD) of the National Institutes of Health (NIH). This means that Acidemia, methylmalonic, or a subtype of Acidemia, methylmalonic, affects less than 200,000 people in the US population.

About prevalence and incidence statistics:

The term 'prevalence' of Acidemia, methylmalonic usually refers to the estimated population of people who are managing Acidemia, methylmalonic at any given time. The term 'incidence' of Acidemia, methylmalonic refers to the annual diagnosis rate, or the number of new cases of Acidemia, methylmalonic diagnosed each year. Hence, these two statistics types can differ: a short-lived disease like flu can have high annual incidence but low prevalence, but a life-long disease like diabetes has a low annual incidence but high prevalence. For more information see about prevalence and incidence statistics.


By using this site you agree to our Terms of Use. Information provided on this site is for informational purposes only; it is not intended as a substitute for advice from your own medical team. The information on this site is not to be used for diagnosing or treating any health concerns you may have - please contact your physician or health care professional for all your medical needs. Please see our Terms of Use.

Home | Symptoms | Diseases | Diagnosis | Videos | Tools | Forum | About Us | Terms of Use | Privacy Policy | Site Map | Advertise